SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
“World’s Fattest Mouse” Appears Immune To Diabetes, UT Southwestern Medical Center Study
August 24, 2007
 · 
1 min read
Lone Star Bio
Eye-Staining Technique Offers Early Detection for Dry Eye Syndrome, UT Southwestern Medical Center Study
August 20, 2007
 · 
1 min read
Lone Star Bio
Combination of Limes, Sun Can Result in ‘Margarita Dermatitis’
August 16, 2007
 · 
1 min read
Drug Development
UT Southwestern Medical Center: Preclinical Study Suggests Organ-Transplant Drug May Aid in Lupus Fight
August 16, 2007
 · 
1 min read
Lone Star Bio
Estrogen Loss Contributes to Obesity, High BP, University of Texas Health Science Center Study
August 14, 2007
 · 
1 min read
Lone Star Bio
New Treatment Effective in Counteracting Cocaine-Induced Symptoms, UT Southwestern Medical Center Study
August 13, 2007
 · 
1 min read
Lone Star Bio
Atrium Medical Corporation Catheters are DEHP-Free
August 10, 2007
 · 
1 min read
Lone Star Bio
Migraines Raise Women’s Stroke Risk: Study
August 10, 2007
 · 
1 min read
Lone Star Bio
Chromatin Remodeling Complex Connected to DNA Damage Control; University of Texas M. D. Anderson Cancer Center Study
August 10, 2007
 · 
1 min read
Lone Star Bio
Statin Drugs May Delay Progressive Artery Damage in Children with Inherited Cholesterol Disease
August 10, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More